Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Orthopedics
MedTech
Globus Medical to buy neurostim developer Nevro for $250M
With Globus paying $5.85 for each of Nevro’s outstanding shares, that amounts to a 27% premium over a 90-day weighted average.
Conor Hale
Feb 10, 2025 10:51am
Stryker to sell spinal implant business as new spinout
Jan 29, 2025 10:59am
Zimmer Biomet nets foot-and-ankle specialist Paragon 28 for $1B
Jan 29, 2025 10:00am
Zimmer Biomet's cement-alternative knee implants collect FDA OKs
Dec 4, 2024 11:30am
FDA elevates recall as Zimmer Biomet phases out hip implant
Sep 17, 2024 2:40pm
Zimmer Biomet scoops up OrthoGrid to expand hip portfolio
Aug 9, 2024 11:30am
